newsfilter
← Latest News
Business Wire·

Intersect ENT Announces Preliminary Revenue for Fourth Quarter of 2020

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced preliminary fourth quarter 2020 revenue and provided a business update.